Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Abgenix, JT and GenPharm sign crosslicensing agreement for human MAb technologies

April 7, 1997

No Comments

Novel drug delivery system from Brown University shows promise

April 4, 1997

No Comments

Electroporation shown to be effective for local delivery of agents for restenosis

April 3, 1997

No Comments

Sheffield licenses Siemens multidose inhaler

April 3, 1997

No Comments

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

April 2, 1997

No Comments

Inhale granted U.S. patent for pulmonary delivery of osteoporosis drug

March 25, 1997

No Comments

Aprogenex and Centocor sign licensing agreement

March 24, 1997

No Comments

Xenova and Zeneca enter drug discovery collaboration

March 21, 1997

No Comments

Oncogene Science and Sepracor enter drug discovery collaboration

March 20, 1997

No Comments

Oncogene Science granted rights to Dow's compound library

March 20, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Abgenix, JT and GenPharm sign crosslicensing agreement for human MAb technologies

Novel drug delivery system from Brown University shows promise

Electroporation shown to be effective for local delivery of agents for restenosis

Sheffield licenses Siemens multidose inhaler

Preliminary data reported from Alkermes' RMP-7/carboplatin phase II trial

Inhale granted U.S. patent for pulmonary delivery of osteoporosis drug

Aprogenex and Centocor sign licensing agreement

Xenova and Zeneca enter drug discovery collaboration

Oncogene Science and Sepracor enter drug discovery collaboration

Oncogene Science granted rights to Dow's compound library

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS